NASDAQ Heavily traded Stocks -RVBD, HGSI, SWKS, ARMH, ACAS
Riverbed Technology, Inc. (NASDAQ: RVBD) fell -6.74%, to close at $25.72 and its overall traded volume was 5.16M shares during the last session against its average volume of 5.06M. RVBD shares were trading within the range of $24.83-$26.48 while its opening price was $26.20. The stock has a 52 week low of $18.33 and 52 week high of $44.70. The market capitalization of the company stands at $4.00B and it has 155.40M outstanding shares.
Riverbed Technology, Inc. (Riverbed) has developed solutions to the fundamental problems associated with information technology (IT) performance across wide area networks (WANs). Riverbed’s products include solutions for branch offices, mobile workers, private data centers, private clouds and cloud computing. The Company’s products include Steelhead products and Cascade product line. The Company’s solution, the Riverbed Optimization System (RiOS), consists of hardware and software products that address the fundamental performance limitations of distributed computing environments. During the year ended December 31, 2010, it introduced solutions for the public cloud, including a cloud-intelligent WAN optimization solution and a cloud storage accelerator targeting back-up and select archive workloads. In November 2010, the Company acquired Global Protocols LLC (Global Protocols). In October 2010, Riverbed acquired CACE Technologies, Inc. (Cace). In July 2011, it acquired Zeus Technology.
Human Genome Sciences (NASDAQ: HGSI) slid -0.10%, to close at $10.25 and its overall traded volume was 5.12M shares during the last session against its average volume of 6.66M. HGSI opened at $10.08 and is trading within the range of $9.99-$10.47. The stock has a 52 week low of $9.68 and 52 week high of $30.15. At current market price, the market capitalization of the company stands at $1.95B and it has 190.67M outstanding shares. Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company’s products are BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. GlaxoSmithKline (GSK) is a HGS partner in the co-development and commercialization of BENLYSTA. HGS is engaged in the development of targeted agonistic antibody therapies for cancer based on the TRAIL receptor apoptotic pathway. The Company manufactures multiple protein and antibody drugs for use in research, clinical and commercial activities. During the year ended December 31, 2010, HGS continued delivery of raxibacumab to the United States Strategic National Stockpile.
Skyworks Solutions, Inc. (NASDAQ: SWKS) fell -3.53%, to close at $19.11 and its overall traded volume was 5.06M shares during the last session with the total traded volume of 4.62M shares. SWKS shares were trading within the range of $19.00-$19.55 while its opening price was $19.05. The stock has a 52-week range of $16.34-$37.82. The market capitalization of the company stands at $3.56B and it has 186.28M outstanding shares. Skyworks Solutions, Inc. (Skyworks) offers diverse standard and custom linear products supporting automotive, broadband, cellular infrastructure, energy management, industrial, medical, military and cellular handset applications. The Company’s portfolio includes amplifiers, attenuators, detectors, diodes, directional couplers, front-end modules, hybrids, infrastructure radio frequency (RF) subsystems, mixers/demodulators, phase shifters, phase locked loops (PLLs)/synthesizers/VCOs, power dividers/combiners, receivers, switches and technical ceramics. It has aligned its p roduct portfolio around two markets: cellular handsets and analog semiconductors. The handset portfolio includes customized power amplifiers and front-end solutions, from entry level to multimedia platforms and smart phones. Some of its primary handset customers include LG Electronics, Motorola, Nokia, Samsung, Sony Ericsson, Research in Motion, and HTC. In June 2011, the Company acquired SiGe Semiconductor, Inc.
ARM Holdings plc (ADR) (NASDAQ: ARMH) percentage change fell -1.50%, to close at $27.67 and its overall traded volume was 4.91M shares during the last session with the total traded volume of 3.92M shares. ARMH shares were trading within the range of $26.66-$27.98 while its opening price was $26.99. The 52-week range of the stock is $16.46-$32.18. ARMH’s market capitalization is $12.45B and it has 450.00M outstanding shares. ARM Holdings plc (ARM) designs microprocessors, physical intellectual property (IP) and related technology and software, and sells development tools. As of December 31, 2010, the Company operated in three business segments: the Processor Division (PD), the Physical IP Division (PIPD) and the System Design Division (SDD). ARM licenses and sells its technology and products to international electronics companies, which in turn manufactures, markets and sells microprocessors, application-specific integrated circuits (ASICs) and application-specific standard processors (ASSPs) -based on ARM’s technology to systems companies for incorporation into a range of end products. During the year ended December 31, 2010, the Company disposed of its investment in CoWare Inc. In June 2011, the Company acquired Obsidian Software.
American Capital Ltd. (NASDAQ: ACAS) fell -4.50%, to close at $7.42 and its overall traded volume was 4.90M shares during the last session against its average volume of 4.92M. ACAS opened at $7.53 and is trading within the range of $7.39-$7.60. The stock has a 52-week range of $5.98-$10.85. ACAS’s market capitalization is $2.63B and it has 353.82M outstanding shares. American Capital, Ltd. (American Capital) is an equity firm and global asset manager. It invests in private equity, private debt, private real estate securities and other investments, technology investments, special situation investments, alternative asset funds managed by it and structured finance investments. It invests in senior and mezzanine debt and equity in buyouts of private companies sponsored by it (American Capital One-Stop Buyouts) or sponsored by other private equity funds (Private Equity Buyouts) and provide capital directly to early-stage and mature private and small public companies. It also invests in structured financial product investments, including commercial mortgage backed securities, commercial collateralized loan obligation securities and collateralized debt obligation securities and invest in alternative asset funds managed by it. On January 31, 2011, its portfolio company triVIN Holdings, Inc. was acquired by DealerTrack Holdings, Inc.
